Neonatal Nuggets Part 2: tummy troubles

Author: Richard Freeman / Editor: Lauren Fraser / Codes: Published: 18/03/2021

This session will explore common neonatal presentations that could be safely discharged from the ED without necessarily involving the on-call paediatric team. Although, as a caveat, we would always recommend working within your own competence and adhering to local guidelines! The second session will cover common tummy troubles with particular reference to evidence-based management of colic and gastro-oesophageal reflux.

Learning Objectives

By the end of this session you should be able to:

  • Recognise and manage common causes of neonatal vomiting.
  • To be able to recognise and manage cases of gastro-oesophageal reflux in an evidence-based manner.
  • To be able to recognise and manage cases of infantile colic in an evidence-based manner.
  • To be able to recognise and manage common benign neonatal conditions.
  • To reassure parents and provide appropriate safety-net advice as appropriate.

Further reading

  1. Newborn Photo Gallery. Stanford School of Medicine [Online]. [Accessed 18th February 2021].
  2. National Institute for Health and Care Excellence. Gastro-oesophageal reflux disease in children and young people: diagnosis and management [NG1]. London: National Institute for Health and Care Excellence 2010.
  3. Cry-sis [Online]. [Accessed 18th February 2021].

References

  1. Flanagan CF, Stewart M. Factors associated with early neo- natal attendance to a paediatric emergency department. Arch Dis Child 2014;99(3):239-243.
  2. National Institute for Health and Care Excellence. Gastro-oesophageal reflux disease in children and young people: diagnosis and management. NICE guideline [NG1] 2015.
  3. Ratnayake K, Kim TY. Evidence-based management of neonatal vomiting in the emergency department. Pediatr Emerg Med Pract 2014;11(11):1-20.
  4. Flaherman VJ et al. Early Weight Loss Nomograms for Exclusively Breastfed Newborns. Pediatrics 2015;135(1):e16-e23.
  5. Macdonald PD et al. Neonatal weight loss in breast and formula fed infants. Arch Dis Child Fetal Neonatal Ed 2003;88:F472-F476.
  6. Flaherman VJ et al. Early Weight Loss Nomograms for Exclusively Breastfed Newborns. Pediatrics 2014, peds.2014-1532.
  7. Walker GM et al. Colour of bile vomiting in intestinal obstruction in the newborn: questionnaire study. BMJ 2006;332(7554):1363.
  8. Malhotra A, Lakkundi A, Carse E. Bilious vomiting in the newborn: 6 years data from a Level III Centre. J Paediatr Child Health 2010;46(5):259-261.
  9. Godbole P, Stringer MD. Bilious vomiting in the newborn: how often is it pathologic? J Pediatr Surg 2002;37(6):909-911.
  10. Chen A, Du J, Du LZ. Clinical characteristics of abdominal distention in early newborns. Zhongguo Dang Dai Er Ke Za Zhi 2013;15(12):1074-1078.
  11. Shaoul R et al. Clinical presentation of pyloric stenosis: the change is in our hands. Isr Med Assoc J 2004;6(3):134-137.
  12. Benson CD, Lloyd JR. Infantile pyloric stenosis. A review of 1,120 cases. Am J Surg 1964;107:429-433.
  13. Aydin E et al. Role of nasopharyngeal reflux in the etiology of otitis media with effusion. Journal of Otolaryngology 2011;40:499-503.
  14. O’Reilly RC et al. The role of extraesophageal reflux in otitis media in infants and children. Laryngoscope 2008:118:1-9.
  15. Sutphen JL, Dillard VL. Effect of feeding volume on early postcibal gastroesophageal reflux in infants. Journal of Pediatric Gastroenterology and Nutrition 1998;7:185-188.
  16. Buts JP, Barudi C, Otte JB. Double-blind controlled study on the efficacy of sodium alginate (Gaviscon) in reducing gastroesophageal reflux assessed by 24 h continuous pH monitoring in infants and children. European Journal of Pediatrics 1987;146:156-158.
  17. Forbes D, Hodgson M, Hill R. The effects of gaviscon and metoclopramide in gastroesophageal reflux in children. Journal of Pediatric Gastroenterology and Nutrition 1986;5:556-55.
  18. Del, Buono R et al. Effect of Gaviscon Infant on gastro-oesophageal reflux in infants assessed by combined intraluminal impedance/pH, Archives of Disease in Childhood 2005;90:460-463.
  19. Miller S. Comparison of the efficacy and safety of a new aluminium-free paediatric alginate preparation and placebo in infants with recurrent gastro-oesophageal reflux. Current Medical Research and Opinion 1999;15:160-168.
  20. Hussain S et al. Safety and Efficacy of Delayed Release Rabeprazole in 1- to 11-Month-Old Infants With Symptomatic GERD. Journal of Pediatric Gastroenterology and Nutrition 2014;58:233-243.
  21. Omari TI et al. Effect of omeprazole on acid gastroesophageal reflux and gastric acidity in preterm infants with pathological acid reflux. Journal of Pediatric Gastroenterology and Nutrition 2007;44:41-44.
  22. Orenstein SR et al. Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease. Journal of Pediatrics 229;154:514-520.
  23. Davidson G et al. Efficacy and Safety of Once-Daily Esomeprazole for the Treatment of Gastroesophageal Reflux Disease in Neonatal Patients. Journal of Pediatrics 2013;163:692-698.e2.
  24. Simeone D et al. Treatment of childhood peptic esophagitis: a double-blind placebo-controlled trial of nizatidine, Journal of Pediatric Gastroenterology and Nutrition 1997;25:51-55.
  25. Cucchiara S et al. Cimetidine treatment of reflux esophagitis in children: an Italian multicentric study, Journal of Pediatric Gastroenterology and Nutrition 1989;8:150-156.
  26. Leung AKC, Lai PCW. Use of metoclopramide for the treatment of gastroesophageal reflux in infants and children, CURR THER RES, CLIN EXP 1984;36:911-915.
  27. Bines JE et al. Efficacy of domperidone in infants and children with gastroesophageal reflux. Journal of Pediatric Gastroenterology and Nutrition 1992;14:400-405.
  28. Tolia V et al. Randomized, prospective double-blind trial of metoclopramide and placebo for gastroesophageal reflux in infants. Journal of Pediatrics 1989;115:141-145.
  29. Carroccio A et al. Domperidone plus magnesium hydroxide and aluminum hydroxide: a valid therapy in children with gastroesophageal reflux. A double-blind randomized study versus placebo. Scandinavian Journal of Gastroenterology 1994;29:300-304.
  30. Bellissant E et al. The triangular test to assess the efficacy of metoclopramide in gastroesophageal reflux. Clinical Pharmacology and Therapeutics 1997;61:377-384.
  31. Apt L, Downey WS. Melena neonatorium: the swallowed blood syndrome. J Pediatr 1955;47:612.
  32. McCollough M, Sharieff GQ. Common complaints in the first 30 days of life. Emerg Med Clin North Am 2002;20:2748.
  33. Savino F et al. Looking for new treatments of Infantile Colic. Ital J Pediatr 2014;40:53.
  34. Milidou I et al. Gestational age, small for gestational age, and infantile colic. Paediatr Perinat Epidemiol 2014;28(2):138-45.
  35. Savino F, Tarasco V. New treatments for infant colic. Curr Opin Pediatr 2010;22(6):791-7.
  36. Chau K et al. Probiotics for infantile colic: a randomized, double-blind, placebo-controlled trial investigating Lactobacillus reuteri DSM 17938. J Pediatr 2015;166(1):74-8.
  37. Hall B, Chesters J, Robinson A. Infantile colic: a systematic review of medical and conventional therapies. J Paediatr Child Health 2012;48(2):128-37.
  38. Hyman PE et al. Childhood functional gastrointestinal disorders: neonate/toddler. Gastroenterology 2006;130(5):1519-26.
  39. Iacovou M et al. Dietary management of infantile colic: a systematic review. Matern Child Health J 2012;16(6):1319-31.
  40. Management of infantile colic. BMJ 2013;10;347:f4102.
  41. Passwell JH et al. Functional excretion of uric acid in infancy and childhood. Arch Dis Child 1974;49:878-82.

Leave a Reply